SCHEMBL16092498

SCHEMBL16092498

CC(C)c1c(-c2ccco2)[nH]c2c(C#N)cnn2c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 12/20 0.51
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4D Q6B0I6 1/20 0.37
▸ HPGD P15428 2/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ PABPC1 P11940 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ KDM6B O15054 1/20 0.35
▸ KDM5C P41229 1/20 0.35
▸ KDM5D Q9BY66 1/20 0.35
▸ KDM4C Q9H3R0 1/20 0.35
▸ KDM5B Q9UGL1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20427601 0.84 KDM5A (0.39) KDM5AALDH1A1HPGDHSD17B10KDM4E
SCHEMBL16092529 0.83 KDM5A (0.38) KDM5AKDM4DKDM6BKDM5CKDM5D
SCHEMBL16092247 0.83 KDM5A (0.45) KDM5AALDH1A1KDM4DHPGDHSD17B10
SCHEMBL16092234 0.83 KDM5B (0.40) KDM5AKDM4DKDM6BKDM5CKDM5D
SCHEMBL16092361 0.82 KDM5A (0.42) KDM5AALDH1A1KDM4DHPGDHSD17B10
SCHEMBL16092249 0.82 KDM5A (0.47) KDM5AALDH1A1KDM4DHPGDHSD17B10
SCHEMBL16092381 0.82 KDM5A (0.40) KDM5AALDH1A1KDM4DHPGDHSD17B10
SCHEMBL16092239 0.82 KDM5A (0.37) KDM5AKDM4DKDM6BKDM5CKDM5D
SCHEMBL16092332 0.82 KDM5A (0.35) KDM5AKDM4DKDM6BKDM5CKDM5D
SCHEMBL16092305 0.81 TSHR (0.38) KDM5AALDH1A1KDM4DHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
WO-2015135094-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2015-09-17 — — WO disclosed
WO-2014139326-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B KDM5A 1/4885ALDH1A1 1424/4885KDM4D 18/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B KDM5A 1/4885ALDH1A1 1424/4885KDM4D 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback